Archives by date
You are browsing the site archives for March 2017.
As I predicted, Mylan has expanded the EpiPen recall to now include additional lots distributed in the U.S. and other markets in consultation with the U.S. Food and Drug Administration (FDA). The expanded voluntary recall is being initiated in the U.S. and will also extend to additional markets in Europe, Asia, North and South America. […]
I had the great privilege to speak with a reporter yesterday, as he’s doing some research for an article. I offered to seek feedback from my wonderful blog readers about the following: Have you obtained Mylan’s generic EpiPen or faced any issue with it? Is it more complicated to get their generic, rather than a […]
There’s an EpiPen recall in Australia due to a defect that may make it difficult to activate in an emergency (failure to activate or increased force needed to activate). Two reports have been confirmed of the device failing to activate in a batch of about 80,000 devices. We all know that the risk of inadequate […]